CIERA RAY: Open Payments
NPI 1659098986 · LAMAR, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 39 payments from 12 companies in 2025. Trend: 2023 $190 · 2024 $2,109 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 6 | $150 |
| Janssen Biotech, Inc. | 8 | $150 |
| UROGEN PHARMA, INC. | 4 | $100 |
| Boston Scientific Corporation | 1 | $92 |
| Sumitomo Pharma America, Inc. | 4 | $88 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $84 |
| Endo USA, Inc. | 3 | $55 |
| Teleflex LLC | 2 | $53 |
| COLOPLAST CORP | 2 | $52 |
| ABBVIE INC. | 3 | $48 |
Products named: ADSTILADRIN, ERLEADA, Axonics, ORGOVYX, JOURNAVX, XIAFLEX, BARRIGEL, LUPRON DEPOT.
Industry payments across CO — which companies pay providers there.
